Bio-Connect

Anti-MSH6 Antibody [PD00-26]

HA721164
HUABIO
ApplicationsImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetMSH6
100 ul
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    HUABIO
  • Product Name
    Anti-MSH6 Antibody [PD00-26]
  • Delivery Days Customer
    2
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    PD00-26
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2956
  • Target name
    MSH6
  • Target description
    mutS homolog 6
  • Target synonyms
    GTBP, GTMBP, HNPCC5, HSAP, LYNCH5, MMRCS3, MSH-6, p160, DNA mismatch repair protein Msh6, G/T mismatch-binding protein, mutS protein homolog 6, mutS-alpha 160 kDa subunit, mutS-like protein 6, sperm-associated protein
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP52701
  • Protein Name
    DNA mismatch repair protein Msh6
  • Scientific Description
    This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. Tonsil is found to be a recommendable positive tissue control for MSH6. Virtually all mantle zone B-cells must show an at least weak to moderate nuclear staining reaction, while a moderate to strong nuclear staining reaction must be seen in the proliferating germinal centre B-cells. Colon adenocarcinoma with loss of MSH6 expression is recommended as negative tissue control. No nuclear staining reaction should be seen in the neoplastic cells, whereas a nuclear staining reaction must be seen in stromal cells serving as internal positive tissue control.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116161